Histopathological analysis of T1 renal cell carcinoma: Does presentation matter?

被引:3
|
作者
Gupta, Gaurav [1 ]
Das Adhikary, Samiran [1 ]
Kumar, Santosh [1 ]
Chacko, Ninan K. [1 ]
Kekre, Nitin S. [1 ]
Gopalakrishnan, Ganesh [1 ]
机构
[1] Christian Med Coll & Hosp, Dept Urol, Vellore 632004, Tamil Nadu, India
关键词
Incidental; nephron-sparing surgery; renal cell carcinoma;
D O I
10.4103/0970-1591.44257
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To study the differences in the clinico-pathological features of incidental and symptomatic T1 renal cell carcinoma (RCC) and to see, particularly in T1b RCC, if symptomatic presentation has adverse pathological features concerning the oncological safety of elective nephron-sparing surgery (NSS) in this subgroup. Materials and Methods: Of 278 patients who underwent radical nephrectomy for RCC from January 1995 to January 2005, 70 had tumor size up to 7 cm (T1). They were categorized as incidental or symptomatic and as T1a or T1b tumors. Clinico-pathological features were compared between incidental (IRCC) and symptomatic (SRCC) groups. Tumors were analyzed using the 1997 TNM staging and Fuhrman's grade. Results: Of the 70 with T1 tumors, 24 had T1a (IRCC, 12 and SRCC, 12) and 46 had T1b tumors (IRCC, 27 and SRCC, 19). Clear cell was the commonest histology. In T1a cancers, though no significant difference in histopathological pattern and grade was seen between the incidental and symptomatic groups, symptomatic tumors had more papillary, mixed histopathological pattern and higher nuclear grade. Among T1b tumors, 14 had papillary and mixed histology, 12 (86%) of which were symptomatic (P=<0.0001). In T1b, 15 (79%) symptomatic had higher nuclear grade (G2-3) while 22 (81%) incidental had lower Fuhrman's grade (P=<0.0001). Conclusion: Symptomatic T1b RCCs had higher nuclear grade and papillary histology. This difference was statistically significant. This may be relevant when considering elective NSS in symptomatic T1b disease.
引用
收藏
页码:504 / 507
页数:4
相关论文
共 50 条
  • [41] EVALUATION OF CLINICAL AND HISTOPATHOLOGICAL PROGNOSTIC PARAMETERS IN T1 TRANSITIONAL CELL-CARCINOMA (TCC) OF THE URINARY-BLADDER
    MELAMED, J
    SARKIS, A
    ZHANG, ZF
    CORDONCARDO, C
    REUTER, VE
    LABORATORY INVESTIGATION, 1993, 68 (01) : A64 - A64
  • [42] Does knowing the risk of relapse in localized renal cell carcinoma matter?
    Wszolek, Matthew
    BJU INTERNATIONAL, 2019, 123 (02) : 201 - 202
  • [43] Systemic and surgical treatment in renal cell carcinoma: Does timing matter?
    Darr, Christopher
    Hilser, Thomas
    Schrader, Andres Jan
    Huberth, Linda
    Mausbach, Anne
    Janssen, Martin
    Krabbe, Laura-Maria
    Heitplatz, Barbara
    Hadaschik, Boris A.
    Boegemann, Martin
    Schlack, Katrin
    Gruenwald, Viktor
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 417 - 417
  • [44] Application of modified RENAL nephrometry score system in evaluating the retroperitoneal partial nephrectomy for T1 renal cell carcinoma
    Wang, Qinzhang
    Qian, Biao
    Li, Qiang
    Ni, Zhao
    Li, Yinglong
    Wang, Xinmin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (04): : 6482 - 6488
  • [45] Tumor Enucleation vs. Partial Nephrectomy for T1 Renal Cell Carcinoma: A Systematic Review and Meta-Analysis
    Xu, Congcong
    Lin, Caixiu
    Xu, Zhen
    Feng, Sheng
    Zheng, Yichun
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [46] Competing-Risks Analysis in Patients with T1 Squamous Cell Carcinoma of The Penis
    Djajadiningrat, Rosa
    Horenblas, Simon
    BJU INTERNATIONAL, 2013, 111 (4B) : E180 - E180
  • [47] Gene Expression Analysis of Aggressive Clinical T1 Stage Clear Cell Renal Cell Carcinoma for Identifying Potential Diagnostic and Prognostic Biomarkers
    Park, Jee Soo
    Pierorazio, Phillip M.
    Lee, Ji Hyun
    Lee, Hyo Jung
    Lim, Young Soun
    Jang, Won Sik
    Kim, Jongchan
    Lee, Seung Hwan
    Rha, Koon Ho
    Cho, Nam Hoon
    Ham, Won Sik
    CANCERS, 2020, 12 (01)
  • [48] RADICAL CYSTECTOMY FOR CLINICAL T1 BLADDER CANCER: DOES TIMING MATTER?
    Ashrafi, Akbar
    Winter, Matthew
    Cacciamani, Giovanni
    Pearce, Shane
    Miranda, Gus
    Cai, Jie
    Abreu, Andre de Castro
    Djaladat, Hooman
    Daneshmand, Siamak
    Desai, Mihir
    Gill, Inderbir
    Aron, Monish
    JOURNAL OF UROLOGY, 2018, 199 (04): : E1118 - E1118
  • [49] Impact of radiological morphology of clinical T1 renal cell carcinoma on the prediction of upstaging to pathological T3
    Teishima, Jun
    Hayashi, Tetsutaro
    Kitano, Hiroyuki
    Sadahide, Kousuke
    Sekino, Yohei
    Goto, Keisuke
    Inoue, Shogo
    Honda, Yukiko
    Sentani, Kazuhiro
    Awai, Kazuo
    Yasui, Wataru
    Matsubara, Akio
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (04) : 473 - 478
  • [50] Oncologic outcomes of nephron-sparing surgery in patients with T1 multifocal renal cell carcinoma
    Li, G.
    Zhu, D.
    Gao, H.
    Chen, H.
    Li, Y.
    Niu, Y.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21 (06): : 760 - 765